MARKET

PBYI

PBYI

Puma Biotechnology Inc
NASDAQ
8.14
-0.26
-3.04%
Pre Market: 8.30 +0.16 +1.97% 04:41 11/11 EST
OPEN
8.35
PREV CLOSE
8.40
HIGH
8.56
LOW
8.06
VOLUME
399
TURNOVER
0
52 WEEK HIGH
11.50
52 WEEK LOW
4.575
MARKET CAP
420.19M
P/E (TTM)
15.78
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PBYI last week (1102-1106)?
Weekly Report · 2d ago
Puma Biotechnology (PBYI) Q3 2026 Earnings Call Transcript
The Motley Fool · 4d ago
Puma Biotech (PBYI) Tops Q3 Earnings Estimates
NASDAQ · 5d ago
Puma Biotechnology Q3 2026 Earnings Call Transcript
Benzinga · 5d ago
Puma Biotechnology reports Q3 adjusted EPS 15c vs 21c last year
TipRanks · 5d ago
Puma Biotechnology Non-GAAP EPS of $0.15, revenue of $55.1M
Seeking Alpha · 5d ago
Puma Biotechnology Sees Q4 Sales $67.000M-$70.000M
Benzinga · 5d ago
Puma Biotechnology Narrows FY2026 Sales Guidance from $224.000M-$231.000M to $224.000M-$227.000M
Benzinga · 5d ago
More
About PBYI
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of products to enhance cancer care. The Company is commercializing NERLYNX, an oral version of neratinib, for the treatment of certain HER2-positive breast cancers. NERLYNX is approved in the United States for two indications: the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer following adjuvant trastuzumab-based therapy and for use in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting. The Company is focused on the global development and commercialization of alisertib. Alisertib is a selective, small-molecule inhibitor of Aurora Kinase A that is designed to disrupt mitosis, leading to apoptosis of rapidly proliferating tumor cells.

Webull offers Puma Biotechnology Inc stock information, including NASDAQ: PBYI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBYI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBYI stock methods without spending real money on the virtual paper trading platform.